Literature DB >> 23040590

Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy.

Yoshihisa Matsumura1, Eri Hoshikawa-Nagai, Toru Kubo, Naohito Yamasaki, Takashi Furuno, Hiroaki Kitaoka, Jun Takata, Tetsuro Sugiura, Yoshinori Doi.   

Abstract

Little is known about left ventricular (LV) reverse remodeling (LVRR) in long-term survivors with idiopathic dilated cardiomyopathy. We studied 59 patients with idiopathic dilated cardiomyopathy who had a potential clinical and echocardiographic follow-up period of >12 years. LVRR was defined as LV end-diastolic dimension ≤ 55 mm and fractional shortening ≥ 25% on the last echocardiogram. Of the 59 patients, 38 died (heart failure in 20, sudden death in 11, and other causes in 7), 2 underwent transplantation, and 19 survived. In the survivors, the LV size had significantly decreased and LV fractional shortening had significantly increased on the last echocardiogram. LVRR occurred in 37% of the survivors. The remaining 63% of the survivors still had LV dysfunction, but the LV end-systolic dimension had decreased significantly. In patients who died or underwent transplantation, the LV size significantly increased. No patient who died or underwent transplantation had LVRR. In conclusion, >60% of the long-term (>12 years) survivors with idiopathic dilated cardiomyopathy still had LV systolic dysfunction, but the LV end-systolic dimension had decreased significantly. In contrast, patients who died or underwent transplantation had significant LV enlargement. These results suggest that LVRR, even if it is not marked, is associated with a favorable prognosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23040590     DOI: 10.1016/j.amjcard.2012.08.056

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Authors:  Melanie D Everitt; Lynn A Sleeper; Minmin Lu; Charles E Canter; Elfriede Pahl; James D Wilkinson; Linda J Addonizio; Jeffrey A Towbin; Joseph Rossano; Rakesh K Singh; Jacqueline Lamour; Steven A Webber; Steven D Colan; Renee Margossian; Paul F Kantor; John L Jefferies; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

Review 2.  Role of non-invasive imaging in the work-up of cardiomyopathies.

Authors:  Lakshmi S Tummala; Raymond K Young; Tania Singh; Sandeep Jani; Monvadi B Srichai
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

3.  Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Yuki Ikeda; Takayuki Inomata; Yuichiro Iida; Miwa Iwamoto-Ishida; Takeru Nabeta; Shunsuke Ishii; Takanori Sato; Tomoyoshi Yanagisawa; Tomohiro Mizutani; Takashi Naruke; Toshimi Koitabashi; Ichiro Takeuchi; Mototsugu Nishii; Junya Ako
Journal:  Heart Vessels       Date:  2015-02-17       Impact factor: 2.037

Review 4.  The efficacy and safety of Sacubitril/Valsartan in the treatment of chronic heart failure: a meta-analysis.

Authors:  Caiyun Zheng; Hengfen Dai; Jungao Huang; Meimei Lin; Qiaowen Zheng; Pujing Tang; Jingwen Xiao; Yan Zhang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 5.  Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure.

Authors:  José Rosino de Araújo Rocha Reis Filho; Juliano Novaes Cardoso; Cristina Martins dos Reis Cardoso; Antonio Carlos Pereira-Barretto
Journal:  Arq Bras Cardiol       Date:  2015-03-27       Impact factor: 2.000

6.  Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.

Authors:  Yoshihisa Matsumura; Eri Hoshikawa-Nagai; Toru Kubo; Naohito Yamasaki; Hiroaki Kitaoka; Jun Takata; Yoshinori Doi; Tetsuro Sugiura
Journal:  Cardiovasc Ultrasound       Date:  2015-03-25       Impact factor: 2.062

7.  Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist?

Authors:  Marco Merlo; Davide Stolfo; Marco Anzini; Francesco Negri; Bruno Pinamonti; Giulia Barbati; Federica Ramani; Andrea Di Lenarda; Gianfranco Sinagra
Journal:  J Am Heart Assoc       Date:  2015-01-13       Impact factor: 5.501

8.  Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.

Authors:  Heiner Latus; Kerstin Gummel; Karin Klingel; Axel Moysich; Markus Khalil; Nona Mazhari; Juergen Bauer; Reinhard Kandolf; Dietmar Schranz; Christian Apitz
Journal:  J Cardiovasc Magn Reson       Date:  2015-05-15       Impact factor: 5.364

Review 9.  Oral Chinese Herbal Medicine for Treatment of Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis.

Authors:  Yu-Shuo Zhu; Yun-Lun Li; Jian-Qing Ju; Feng Du; Yan-Ping Zang; Xiao-Bing Wang; Jie Sheng
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-18       Impact factor: 2.629

Review 10.  Myocardial remodelling and recovery in dilated cardiomyopathy.

Authors:  Upasana Tayal; Sanjay K Prasad
Journal:  JRSM Cardiovasc Dis       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.